SCHEMBL20501020

SCHEMBL20501020

CCCCc1ccc(NC(=O)Nc2cc(-c3cnc(N)[nH]3)ccc2F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA9 Q16790 3/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
TRPV1 Q8NER1 1/20 0.44
KDR P35968 9/20 0.43
LCK P06239 2/20 0.43
CSF1R P07333 2/20 0.43
LYN P07948 2/20 0.43
FLT1 P17948 2/20 0.43
FLT4 P35916 2/20 0.43
FLT3 P36888 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20500986 0.84 MEN1 (0.54) CA12CA1CA2CA9MEN1
SCHEMBL20500971 0.79 SLC2A1 (0.52) CA2CA9MEN1KMT2ANPC1
SCHEMBL24176904 0.79 RAB9A (0.49) CA2MEN1KMT2ANPC1RAB9A
SCHEMBL20501022 0.78 SCN9A (0.50) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL13655214 0.78 SCN9A (0.54) NPC1RAB9ATRPV1S1PR4S1PR1
SCHEMBL20501151 0.78 SCN4A (0.44) CA12CA1CA2CA9MEN1
SCHEMBL20501046 0.76 KDR (0.44) KDRLCKCSF1RLYNFLT1
SCHEMBL20501048 0.74 SCN9A (0.64) RAB9AKDRROCK2PDGFRBMAPT
SCHEMBL20501115 0.74 SCN9A (0.52) MEN1KMT2ANPC1RAB9AKDR
SCHEMBL24176655 0.73 SCN4A (0.49) MEN1KMT2ANPC1RAB9AKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth NORTH CAROLINA STATE UNIVERSITY (US) 2023-02-21 US disclosed
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-01-06 US disclosed
CN-110740645-A 2-aminoimidazole-phenyl derivatives for controlling microbial growth 北卡罗莱纳州立大学 2020-01-31 CN disclosed
WO-2018169752-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH NORTH CAROLINA STATE UNIVERSITY (US) 2018-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth DDC, IL4I1, ING2 CA12 4757/4885CA1 4750/4885CA2 1994/4885
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH DDC, IL4I1, ING2 CA12 4757/4885CA1 4750/4885CA2 1994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.